Alexander Macrae
Chief Executive Officer chez SANGAMO THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Alexander D.
Macrae is currently the President, Chief Executive Officer & Director at Sangamo Therapeutics, Inc. and an Independent Non-Executive Director at 4D Pharma Plc.
He is also a Member of The Royal College of Physicians.
Previously, he worked as the Global Medical Officer at Takeda Pharmaceuticals U.S.A., Inc. from 2012 to 2016 and as the Senior VP-Emerging Markets Research & Development at GlaxoSmithKline LLC from 2009 to 2012.
Macrae received his undergraduate degree from the University of Glasgow in 1986 and his doctorate from King's College, Cambridge in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/02/2024 | 2 552 204 ( 1,25% ) | 2 M $ | 31/03/2024 |
Postes actifs de Alexander Macrae
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Executive Officer | 01/06/2016 |
| 4D PHARMA PLC | Director/Board Member | 27/08/2019 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Anciens postes connus de Alexander Macrae
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Chief Tech/Sci/R&D Officer | 01/03/2016 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/2012 |
Formation de Alexander Macrae
| University of Glasgow | Undergraduate Degree |
| King's College, Cambridge | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
